CHOP Researcher Advances Neuroprotective Efforts for Children With Congenital Heart Disease

Published on in Cardiac Connection

Forty years ago, most children with complex congenital heart disease (CHD) died before reaching adulthood. Now, the vast majority of them survive. But half of all children who have heart surgery as infants experience significant neurodevelopmental problems — including behavioral issues and learning difficulties — later on.

CHOP neurologist Daniel Licht, MD, who cares for children with CHD as part of the Hospital’s Cardiac Kids Developmental Follow-up Program, is leading research to determine why these problems are so prevalent in children with CHD and how they can be prevented.

An ‘a-ha’ moment

MRI scans performed in infants who have undergone early heart surgery for CHD show that more than 50 percent have an injury to the white matter of their brains. But it was another finding — that 20 percent of these babies show evidence of white matter injury prior to surgery — that was the “a-ha” moment for Licht. It was clear that for some babies, the risk of neurologic injury was highest not during or after surgery, as many believed, but before it. Licht’s early research focused on identifying Dr. Licht and Abbyrisk for brain injury before surgery and led to an understanding that the heart defect had a profound effect on brain development and growth.

But what could be done to mitigate that risk? Licht and his team now use two types of imaging to better understand brain injury risk: MRI and optics (near-infrared light). Brain MRIs were done before and after surgery, and optical measurements of cerebral blood flow and brain oxygen saturations were taken from just after birth to just before surgery, and for 12 hours after surgery. They found that the longer an infant waits for surgery, the lower the brain oxygen saturations fall. Lower brain oxygen saturations were very predictive of brain injury before and after surgery.

“It’s the condition in which they go into surgery that makes the difference,” says Licht. “You can’t do surgery fast enough for these kids.” Licht’s work could lead to changes in surgical practice — and has also led to a new question: “If the most important thing is the health of the brain before surgery, what does that say about fetal life?” asks Licht, who is working with cardiothoracic surgeon J. William Gaynor, MD, and Jack Rychik, MD, director of the Fetal Heart Program, to identify drugs that can be given to a woman expecting a baby with CHD to protect the brain of her developing fetus.

“That really is the next frontier for this research,” he says. “Instead of focusing on protecting the brain during and after surgery, we want to find ways to protect the fetus’ brain before birth.”